5Chin J H, Abdelhadi RH, Chung MK, et al. Effect of statin ther --apy on risk of ventricular arrhythm in among patients withcoronary artery disease and an inplantable cardioverter--defibril --lator[J]. Am J Cardiol,2005,95(4):490-491.
6Amareneo P, Bogousslavsky J,Callahan A, et al. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High--dose atorvastatin after stroke or transient ischemic attack[J]. N Engl J Med,2006,355:549-559.
9Castilla - Guerra L, Fern6ndez - Moreno MC, L6pez - Chozas JM , et al. Statins and cerebrovascular disease: new perspectives in stroke prevention [ J ]. Rev Neurol, 2007, 44 (2) :95 - 100.
10Canard SE, Bays HE, Leiter LA, et al. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvaslatin ( to 40 mg) in hypercholesterolemic patients at moder- ately high risk for coronary heart disease [ J ]. Am J Cardiol, 2008, 102 ( 11 ) : 1489 - 1494.
